R version: R version 3.6.0 (2019-04-26)
Bioconductor version: 3.9
Package: 1.8.0
RNA sequencing (RNA-seq) has become a very widely used technology for profiling gene expression. One of the most common aims of RNA-seq profiling is to identify genes or molecular pathways that are differentially expressed (DE) between two or more biological conditions. This article demonstrates a computational workflow for the detection of DE genes and pathways from RNA-seq data by providing a complete analysis of an RNA-seq experiment profiling epithelial cell subsets in the mouse mammary gland. The workflow uses R software packages from the open-source Bioconductor project and covers all steps of the analysis pipeline, including alignment of read sequences, data exploration, differential expression analysis, visualization and pathway analysis. Read alignment and count quantification is conducted using the Rsubread package and the statistical analyses are performed using the edgeR package. The differential expression analysis uses the quasi-likelihood functionality of edgeR.
RNA sequencing (RNA-seq) has become a very widely used technology for profiling transcriptional activity in biological systems. One of the most common aims of RNA-seq profiling is to identify genes or molecular pathways that are differentially expressed (DE) between two or more biological conditions. Changes in expression can then be associated with differences in biology, providing avenues for further investigation into potential mechanisms of action.
This article provides a detailed workflow for analyzing an RNA-seq study all the way from the raw reads through to differential expression and pathway analysis using Bioconductor packages (Huber et al. 2015). The article gives a complete analysis of RNA-seq data that were collected to study the effects of pregnancy and lactation on the luminal cell lineage in the mouse mammary gland (Fu et al. 2015). The pipeline uses the Rsubread package (Liao, Smyth, and Shi 2013) for mapping reads and assigning them to genes and the edgeR package (Robinson, McCarthy, and Smyth 2010) for statistical analyses.
A journal article version of this workflow, including referee reports and responses, is available at F1000Research (Chen, Lun, and Smyth 2016).
RNA-seq analysis involves a number of steps, including read alignment, read summarization, differential expression and pathway analysis. Here we use the Subread aligner (Liao, Smyth, and Shi 2013) for mapping and featureCounts (Liao, Smyth, and Shi 2014) for assigning reads to genes. As well as being fast and efficient, these algorithms have the advantage of having native implementations as R functions in the Rsubread package. This means that the entire analysis can be conducted efficiently within the R environment.
The workflow uses edgeR’s quasi-likelihood pipeline (edgeR-quasi) for differential expression. This statistical methodology uses negative binomial generalized linear models (McCarthy, Chen, and Smyth 2012) but with F-tests instead of likelihood ratio tests (Lund et al. 2012). This method provides stricter error rate control than other negative binomial based pipelines, including the traditional edgeR pipelines (Robinson and Smyth 2008, 2007; McCarthy, Chen, and Smyth 2012) or DESeq2 (Love, Huber, and Anders 2014). The edgeR-quasi pipeline is based on similar statistical methodology to that of the QuasiSeq package (Lund et al. 2012), which has performed well in third-party comparisons (Burden, Qureshi, and Wilson 2014). Compared to QuasiSeq, the edgeR functions offer speed improvements and some additional statistical refinements (Lun, Chen, and Smyth 2016). The RNA-seq pipelines of the limma package also offer excellent error rate control (Law et al. 2014; Ritchie et al. 2015). While the limma pipelines are recommended for large-scale datasets, because of their speed and flexibility, the edgeR-quasi pipeline gives better performance in low-count situations (Lun and Smyth 2014, 2015). For the data analyzed here, the edgeR-quasi, limma-voom and limma-trend pipelines are all equally suitable and give similar results.
The analysis approach illustrated in this article can be applied to any RNA-seq study that includes some replication, but it is especially appropriate for designed experiments with multiple treatment factors and with small numbers of biological replicates. The approach assumes that RNA samples have been extracted from cells of interest under two or more treatment conditions, that RNA-seq profiling has been applied to each RNA sample and that there are independent biological replicates for at least one of the treatment conditions. The Rsubread part of the workflow takes FASTQ files of raw sequence reads as input, while the edgeR part of the pipeline takes a matrix of genewise read counts as input.
This workflow demonstrates a complete bioinformatics analysis of an RNA-seq study that is available from the GEO repository as series GSE60450. The RNA-seq data were collected to study the lineage of luminal cells in the mouse mammary gland and in particular how the expression profiles of the members of the lineage change upon pregnancy and lactation (Fu et al. 2015). Specifically, the study examined the expression profiles of basal stem-cell enriched cells (B) and committed luminal cells (L) in the mammary glands of virgin, pregnant and lactating mice. There are therefore six groups of RNA samples, one for each combination of cell type and mouse status. Two biological replicates were collected for each group.
This study used an Illumina Hiseq sequencer to generate about 30 million 100bp single-end reads for each sample. Subread version 1.4.4 (http://subread.sourceforge.net) was used to align the reads to the mouse mm10 genome and featureCounts was used to assign reads to Entrez Genes using RefSeq gene annotation. The FASTQ files containing the raw sequence reads were deposited to the Sequence Read Archive (SRA) repository and the read counts were deposited to GEO.
This experimental design is summarized in the table below, where the basal and luminal cell types are abbreviated with B
and L
respectively.
The GEO and SRA identifiers for each RNA sample are also shown:
> library(RnaSeqGeneEdgeRQL)
> targetsFile <- system.file("extdata", "targets.txt",
+ package="RnaSeqGeneEdgeRQL")
> targets <- read.delim(targetsFile, stringsAsFactors=FALSE)
> targets
GEO SRA CellType Status
MCL1.DG GSM1480297 SRR1552450 B virgin
MCL1.DH GSM1480298 SRR1552451 B virgin
MCL1.DI GSM1480299 SRR1552452 B pregnant
MCL1.DJ GSM1480300 SRR1552453 B pregnant
MCL1.DK GSM1480301 SRR1552454 B lactating
MCL1.DL GSM1480302 SRR1552455 B lactating
MCL1.LA GSM1480291 SRR1552444 L virgin
MCL1.LB GSM1480292 SRR1552445 L virgin
MCL1.LC GSM1480293 SRR1552446 L pregnant
MCL1.LD GSM1480294 SRR1552447 L pregnant
MCL1.LE GSM1480295 SRR1552448 L lactating
MCL1.LF GSM1480296 SRR1552449 L lactating
The experiment can be viewed as a one-way layout with six groups. For later use, we combine the treatment factors into a single grouping factor:
> group <- paste(targets$CellType, targets$Status, sep=".")
> group <- factor(group)
> table(group)
group
B.lactating B.pregnant B.virgin L.lactating L.pregnant L.virgin
2 2 2 2 2 2
Note. This study isolated carefully sorted cell populations obtained from genetically indentical mice under controlled laboratory conditions. As will be shown during the analysis below, the relatively small sample size (\(n=2\) in each group) here is justified by the low background variability and by the fact that the expression profiles of the different groups are distinctly different. Studies with more variability (for example on human subjects) or with smaller effect sizes may well require more biological replicates for reliable results.
Readers wishing to reproduce the analysis presented in this article can either download the matrix of read counts from GEO or recreate the read count matrix from the raw sequence counts. We will present first the analysis using the downloaded matrix of counts. At the end of this article we will present the R commands needed to recreate this matrix.
The following commands download the genewise read counts for the GEO series GSE60450.
The zipped tab-delimited text file GSE60450_Lactation-GenewiseCounts.txt.gz
will be downloaded to the working R directory:
> FileURL <- paste(
+ "http://www.ncbi.nlm.nih.gov/geo/download/?acc=GSE60450",
+ "format=file",
+ "file=GSE60450_Lactation-GenewiseCounts.txt.gz",
+ sep="&")
> download.file(FileURL, "GSE60450_Lactation-GenewiseCounts.txt.gz")
The counts can then be read into a data.frame in R:
> GenewiseCounts <- read.delim("GSE60450_Lactation-GenewiseCounts.txt.gz",
+ row.names="EntrezGeneID")
> colnames(GenewiseCounts) <- substring(colnames(GenewiseCounts),1,7)
> dim(GenewiseCounts)
[1] 27179 13
> head(GenewiseCounts)
Length MCL1.DG MCL1.DH MCL1.DI MCL1.DJ MCL1.DK MCL1.DL MCL1.LA
497097 3634 438 300 65 237 354 287 0
100503874 3259 1 0 1 1 0 4 0
100038431 1634 0 0 0 0 0 0 0
19888 9747 1 1 0 0 0 0 10
20671 3130 106 182 82 105 43 82 16
27395 4203 309 234 337 300 290 270 560
MCL1.LB MCL1.LC MCL1.LD MCL1.LE MCL1.LF
497097 0 0 0 0 0
100503874 0 0 0 0 0
100038431 0 0 0 0 0
19888 3 10 2 0 0
20671 25 18 8 3 10
27395 464 489 328 307 342
The row names of GenewiseCounts
are the Entrez Gene Identifiers.
The first column contains the length of each gene, being the total number of bases in exons and UTRs for that gene.
The remaining 12 columns contain read counts and correspond to rows of targets
.
The edgeR package stores data in a simple list-based data object called a DGEList
.
This object is easy to use as it can be manipulated like an ordinary list in R, and it can also be subsetted like a matrix.
The main components of a DGEList
object are a matrix of read counts, sample information in the data.frame
format and optional gene annotation.
We enter the counts into a DGEList
object using the function DGEList
in edgeR:
> library(edgeR)
> y <- DGEList(GenewiseCounts[,-1], group=group,
+ genes=GenewiseCounts[,1,drop=FALSE])
> options(digits=3)
> y$samples
group lib.size norm.factors
MCL1.DG B.virgin 23227641 1
MCL1.DH B.virgin 21777891 1
MCL1.DI B.pregnant 24100765 1
MCL1.DJ B.pregnant 22665371 1
MCL1.DK B.lactating 21529331 1
MCL1.DL B.lactating 20015386 1
MCL1.LA L.virgin 20392113 1
MCL1.LB L.virgin 21708152 1
MCL1.LC L.pregnant 22241607 1
MCL1.LD L.pregnant 21988240 1
MCL1.LE L.lactating 24723827 1
MCL1.LF L.lactating 24657293 1
The Entrez Gene Ids link to gene information in the NCBI database.
The org.Mm.eg.db package can be used to complement the gene annotation information.
Here, a column of gene symbols is added to y$genes
:
> library(org.Mm.eg.db)
> y$genes$Symbol <- mapIds(org.Mm.eg.db, rownames(y),
+ keytype="ENTREZID", column="SYMBOL")
> head(y$genes)
Length Symbol
497097 3634 Xkr4
100503874 3259 Gm19938
100038431 1634 Gm10568
19888 9747 Rp1
20671 3130 Sox17
27395 4203 Mrpl15
Entrez Ids that no longer have official gene symbols are dropped from the analysis.
The whole DGEList
object, including annotation as well as counts, can be subsetted by rows as if it was a matrix:
> y <- y[!is.na(y$genes$Symbol), ]
> dim(y)
[1] 26143 12
Linear modeling and differential expression analysis in edgeR requires a design matrix to be specified. The design matrix records which treatment conditions were applied to each samples, and it also defines how the experimental effects are parametrized in the linear models. The experimental design for this study can be viewed as a one-way layout and the design matrix can be constructed in a simple and intuitive way by:
> design <- model.matrix(~0+group)
> colnames(design) <- levels(group)
> design
B.lactating B.pregnant B.virgin L.lactating L.pregnant L.virgin
1 0 0 1 0 0 0
2 0 0 1 0 0 0
3 0 1 0 0 0 0
4 0 1 0 0 0 0
5 1 0 0 0 0 0
6 1 0 0 0 0 0
7 0 0 0 0 0 1
8 0 0 0 0 0 1
9 0 0 0 0 1 0
10 0 0 0 0 1 0
11 0 0 0 1 0 0
12 0 0 0 1 0 0
attr(,"assign")
[1] 1 1 1 1 1 1
attr(,"contrasts")
attr(,"contrasts")$group
[1] "contr.treatment"
This design matrix simply links each group to the samples that belong to it. Each row of the design matrix corresponds to a sample whereas each column represents a coefficient corresponding to one of the six groups.
Genes that have very low counts across all the libraries should be removed prior to downstream analysis. This is justified on both biological and statistical grounds. From biological point of view, a gene must be expressed at some minimal level before it is likely to be translated into a protein or to be considered biologically important. From a statistical point of view, genes with consistently low counts are very unlikely be assessed as significantly DE because low counts do not provide enough statistical evidence for a reliable judgement to be made. Such genes can therefore be removed from the analysis without any loss of information.
As a rule of thumb, we require that a gene have a count of at least 10 or so in at least some libraries before it is considered to be expressed in the study. In practice, the filtering is actually based on count-per-million (CPM) values so as to avoid favoring genes that are expressed in larger libraries over those expressed in smaller libraries. In edgeR, the filtering can be accomplished using a function that takes into account the library sizes and the experimental design:
> keep <- filterByExpr(y, design)
> table(keep)
keep
FALSE TRUE
10407 15736
The DGEList
object is then subsetted to retain only the non-filtered genes:
> y <- y[keep, , keep.lib.sizes=FALSE]
The option keep.lib.sizes=FALSE
causes the library sizes to be recomputed after the filtering.
This is generally recommended, although the effect on the downstream analysis is usually small.
The filterByExpr
function attempts to keep the maximum number of interesting genes in the analysis, but other sensible filtering criteria are also possible.
For example keep <- rowSums(y$counts) > 50
is a very simple criterion that would keep genes with a total read count of more than 50.
This would give similar downstream results for this dataset to the filtering actually used.
Another sensible filter rule would be to compute the average-log-CPM for each gene, and to choose a cutoff value heuristically:
> AveLogCPM <- aveLogCPM(y)
> hist(AveLogCPM)
Again this might give similar downstream results for this data to the filtering actually used.
Whatever the filtering rule, it should be independent of the information in the targets file. It should not make any reference to which RNA libraries belong to which group, because doing so would bias the subsequent differential expression analysis.
Normalization by trimmed mean of M values (TMM) (Robinson and Oshlack 2010) is performed by using the calcNormFactors
function, which returns the DGEList
argument with only the norm.factors
changed.
It calculates a set of normalization factors, one for each sample, to eliminate composition biases between libraries.
The product of these factors and the library sizes defines the effective library size, which replaces the original library size in all downstream analyses.
> y <- calcNormFactors(y)
> y$samples
group lib.size norm.factors
MCL1.DG B.virgin 23112854 1.237
MCL1.DH B.virgin 21659854 1.213
MCL1.DI B.pregnant 23951204 1.126
MCL1.DJ B.pregnant 22521274 1.070
MCL1.DK B.lactating 21402893 1.037
MCL1.DL B.lactating 19901726 1.088
MCL1.LA L.virgin 20246050 1.370
MCL1.LB L.virgin 21541575 1.367
MCL1.LC L.pregnant 22098630 1.005
MCL1.LD L.pregnant 21859483 0.923
MCL1.LE L.lactating 24647412 0.528
MCL1.LF L.lactating 24589787 0.534
The normalization factors of all the libraries multiply to unity. A normalization factor below one indicates that a small number of high count genes are monopolizing the sequencing, causing the counts for other genes to be lower than would be usual given the library size. As a result, the effective library size will be scaled down for that sample. Here we see that the luminal-lactating samples have low normalization factors. This is a sign that these samples contain a number of very highly upregulated genes.
Note. In general, we find TMM normalization to be satisfactory for almost all well-designed mRNA gene expression experiments. Single-cell RNA-seq is an exception, for which specialized normalization methods are needed (Lun, Bach, and Marioni 2016). Another, less common, type of study requiring special treatment is that with global differential expression, with more than half of the genome differentially expressed between experimental conditions in the same direction (Wu et al. 2013). Global differential expression should generally be avoided in well designed experiments. When it can’t be avoided, then some normalization reference such as spike-ins needs to be built into the experiment for reliable normalization to be done (Risso et al. 2014).
The RNA samples can be clustered in two dimensions using multi-dimensional scaling (MDS) plots. This is both an analysis step and a quality control step to explore the overall differences between the expression profiles of the different samples. Here we decorate the MDS plot to indicate the cell groups:
> pch <- c(0,1,2,15,16,17)
> colors <- rep(c("darkgreen", "red", "blue"), 2)
> plotMDS(y, col=colors[group], pch=pch[group])
> legend("topleft", legend=levels(group), pch=pch, col=colors, ncol=2)
In the MDS plot, the distance between each pair of samples can be interpreted as the leading log-fold change between the samples for the genes that best distinguish that pair of samples. By default, leading fold-change is defined as the root-mean-square of the largest 500 log2-fold changes between that pair of samples. The figure above shows that replicate samples from the same group cluster together while samples from different groups are well separated. In other words, differences between groups are much larger than those within groups, meaning that there are likely to be statistically significant differences between the groups. The distance between basal cells on the left and luminal cells on the right is about six units on the x-axis, corresponding to a leading fold change of about 64-fold between the two cell types. The differences between the virgin, pregnant and lactating expression profiles appear to be magnified in luminal cells compared to basal.
The expression profiles of individual samples can be explored more closely with mean-difference (MD) plots. An MD plot visualizes the library size-adjusted log-fold change between two libraries (the difference) against the average log-expression across those libraries (the mean). The following command produces an MD plot that compares sample 1 to an artificial reference library constructed from the average of all the other samples:
> plotMD(y, column=1)
> abline(h=0, col="red", lty=2, lwd=2)
The bulk of the genes are centered around the line of zero log-fold change. The diagonal lines in the lower left of the plot correspond to genes with counts of 0, 1, 2 and so on in the first sample.
It is good practice to make MD plots for all the samples as a quality check. We now look at one of the luminal-lactating samples that was observed have a low normalization factor:
> plotMD(y, column=11)
> abline(h=0, col="red", lty=2, lwd=2)
For this sample, the log-ratios show noticeable positive skew, with a number of very highly upregulated genes. In particular, there are a number of points in the upper right of the plot, corresponding to genes that are both highly expressed and highly up-regulated in this sample compared to others. These genes explain why the normalization factor for this sample is well below one. By contrast, the log-ratios for sample 1 were somewhat negatively skewed, corresponding to a normalization factor above one.
edgeR uses the negative binomial (NB) distribution to model the read counts for each gene in each sample.
The dispersion parameter of the NB distribution accounts for variability between biological replicates (McCarthy, Chen, and Smyth 2012).
edgeR estimates an empirical Bayes moderated dispersion for each individual gene.
It also estimates a common dispersion, which is a global dispersion estimate averaged over all genes, and a trended dispersion where the dispersion of a gene is predicted from its abundance.
Dispersion estimates are most easily obtained from the estimateDisp
function:
> y <- estimateDisp(y, design, robust=TRUE)
This returns a DGEList
object with additional components (common.dispersion
, trended.dispersion
and tagwise.dispersion
) added to hold the estimated dispersions.
Here robust=TRUE
has been used to protect the empirical Bayes estimates against the possibility of outlier genes with exceptionally large or small individual dispersions (Phipson et al. 2016).
The dispersion estimates can be visualized with plotBCV
:
> plotBCV(y)
The vertical axis of the plotBCV
plot shows square-root dispersion, also known as biological coefficient of variation (BCV) (McCarthy, Chen, and Smyth 2012).
For RNA-seq studies, the NB dispersions tend to be higher for genes with very low counts.
The dispersion trend tends to decrease smoothly with abundance and to asymptotic to a constant value for genes with larger counts.
From our past experience, the asymptotic value for the BCV tends to be in range from 0.05 to 0.2 for genetically identical mice or cell lines, whereas somewhat larger values (\(>0.3\)) are observed for human subjects.
The NB model can be extended with quasi-likelihood (QL) methods to account for gene-specific variability from both biological and technical sources (Lund et al. 2012; Lun, Chen, and Smyth 2016). Under the QL framework, the NB dispersion trend is used to describe the overall biological variability across all genes, and gene-specific variability above and below the overall level is picked up by the QL dispersion. In the QL approach, the individual (tagwise) NB dispersions are not used.
The estimation of QL dispersions is performed using the glmQLFit
function:
> fit <- glmQLFit(y, design, robust=TRUE)
> head(fit$coefficients)
B.lactating B.pregnant B.virgin L.lactating L.pregnant L.virgin
497097 -11.13 -12.01 -11.22 -19.0 -19.03 -19.0
20671 -12.76 -12.51 -12.15 -14.5 -14.30 -14.1
27395 -11.27 -11.29 -11.53 -10.6 -10.86 -10.9
18777 -10.15 -10.21 -10.76 -10.1 -10.38 -10.4
21399 -9.89 -9.73 -9.78 -10.2 -9.97 -10.0
58175 -16.15 -14.85 -15.98 -13.3 -12.29 -12.0
This returns a DGEGLM
object with the estimated values of the GLM coefficients for each gene.
It also contains a number of empirical Bayes (EB) statistics including the QL dispersion trend, the squeezed QL dispersion estimates and the prior degrees of freedom (df).
The QL dispersions can be visualized by plotQLDisp
:
> plotQLDisp(fit)
The QL functions moderate the genewise QL dispersion estimates in the same way that the limma package moderates variances (Smyth 2004). The raw QL dispersion estimates are squeezed towards a global trend, and this moderation reduces the uncertainty of the estimates and improves testing power. The extent of the squeezing is governed by the value of the prior df estimated from the data. Large prior df estimates indicate that the QL dispersions are less variable between genes, meaning that strong EB moderation should be performed. Smaller prior df estimates indicate that the true unknown dispersions are highly variable, so weaker moderation towards the trend is appropriate.
> summary(fit$df.prior)
Min. 1st Qu. Median Mean 3rd Qu. Max.
2.91 6.84 6.84 6.69 6.84 6.84
Setting robust=TRUE
in glmQLFit
is usually recommended (Phipson et al. 2016).
This allows gene-specific prior df estimates, with lower values for outlier genes and higher values for the main body of genes.
This reduces the chance of getting false positives from genes with extremely high or low raw dispersions, while at the same time increasing statistical power to detect differential expression for the main body of genes.
The next step is to test for differential expression between the experimental groups.
One of the most interesting comparisons is that between the basal pregnant and lactating groups.
The contrast corresponding to any specified comparison can be constructed conveniently using the makeContrasts
function:
> B.LvsP <- makeContrasts(B.lactating-B.pregnant, levels=design)
In subsequent results, a positive \(\log_2\)-fold-change (logFC) will indicate a gene up-regulated in lactating mice relative to pregnant, whereas a negative logFC will indicate a gene more highly expressed in pregnant mice.
We will use QL F-tests instead of the more usual likelihood ratio tests (LRT) as they give stricter error rate control by accounting for the uncertainty in dispersion estimation:
> res <- glmQLFTest(fit, contrast=B.LvsP)
The top DE genes can be viewed with topTags
:
> topTags(res)
Coefficient: 1*B.lactating -1*B.pregnant
Length Symbol logFC logCPM F PValue FDR
12992 765 Csn1s2b 6.08 10.19 422 4.30e-11 6.77e-07
211577 2006 Mrgprf 5.14 2.75 343 1.22e-10 7.28e-07
226101 7094 Myof 2.32 6.45 323 1.78e-10 7.28e-07
381290 8292 Atp2b4 2.14 6.15 321 1.85e-10 7.28e-07
140474 11281 Muc4 -7.18 6.06 309 2.39e-10 7.51e-07
231830 3346 Micall2 -2.25 5.19 283 4.01e-10 1.05e-06
24117 2242 Wif1 -1.82 6.77 260 6.65e-10 1.49e-06
12740 1812 Cldn4 -5.32 9.88 298 8.86e-10 1.66e-06
21953 667 Tnni2 5.75 3.86 314 9.47e-10 1.66e-06
231991 2873 Creb5 2.57 4.87 241 1.07e-09 1.68e-06
In order to control the false discovery rate (FDR), multiple testing correction is performed using the Benjamini-Hochberg method. The top DE gene Csn1s2b has a large positive logFC, showing that it is far more highly expressed in the basal cells of lactating than pregnant mice. This gene is indeed known to be a major source of protein in milk.
The total number of DE genes identified at an FDR of 5% can be shown with decideTestsDGE
.
There are in fact more than 5000 DE genes in this comparison:
> is.de <- decideTestsDGE(res)
> summary(is.de)
1*B.lactating -1*B.pregnant
Down 2752
NotSig 10507
Up 2477
The magnitude of the differential expression changes can be visualized with a fitted model MD plot:
> plotMD(res, status=is.de, values=c(1,-1), col=c("red","blue"),
+ legend="topright")
The logFC for each gene is plotted against the average abundance in log2-CPM, i.e., logCPM
in the table above.
Genes that are significantly DE are highlighted.
glmQLFTest
identifies differential expression based on statistical significance regardless of how small the difference might be.
For some purposes we might be interested only in genes with reasonably large expression changes.
The above analysis found more than 5000 DE genes between the basal pregnant and lactating groups.
With such a large number of DE genes, it makes sense to narrow down the list to genes that are more biologically meaningful.
A commonly used approach is to apply FDR and logFC cutoffs simultaneously.
However this tends to favor lowly expressed genes, and also fails to control the FDR correctly.
A better and more rigorous approach is to modify the statistical test so as to detect expression changes greater than a specified threshold.
In edgeR, this can be done using the glmTreat
function.
This function is analogous to the TREAT method for microarrays (McCarthy and Smyth 2009) but is adapted to the NB framework.
Here we test whether the differential expression fold changes are significantly greater than 1.5, that is, whether the logFCs are significantly greater than \(\log_2(1.5)\):
> tr <- glmTreat(fit, contrast=B.LvsP, lfc=log2(1.5))
> topTags(tr)
Coefficient: 1*B.lactating -1*B.pregnant
Length Symbol logFC unshrunk.logFC logCPM PValue FDR
12992 765 Csn1s2b 6.08 6.09 10.19 5.65e-11 8.89e-07
211577 2006 Mrgprf 5.14 5.15 2.75 1.76e-10 1.38e-06
140474 11281 Muc4 -7.18 -7.34 6.06 3.87e-10 2.03e-06
226101 7094 Myof 2.32 2.32 6.45 9.05e-10 2.71e-06
12740 1812 Cldn4 -5.32 -5.33 9.88 1.17e-09 2.71e-06
21953 667 Tnni2 5.75 5.76 3.86 1.20e-09 2.71e-06
381290 8292 Atp2b4 2.14 2.14 6.15 1.21e-09 2.71e-06
231830 3346 Micall2 -2.25 -2.25 5.19 2.23e-09 4.38e-06
231991 2873 Creb5 2.57 2.57 4.87 3.99e-09 6.97e-06
16012 1289 Igfbp6 2.87 2.87 3.68 5.12e-09 8.05e-06
Note that the argument is an abbreviation for ``log-fold-change“. About 1100 genes are detected as DE with a FC significantly above 1.5 at an FDR cut-off of 5%.
> is.de <- decideTestsDGE(tr)
> summary(is.de)
1*B.lactating -1*B.pregnant
Down 682
NotSig 14686
Up 368
The p-values from glmTreat
are larger than those from glmQLFTest
, and the number of significantly DE genes is fewer, because it is testing an interval null hypothesis and requires stronger evidence for differential expression than does a conventional test.
It provides greater specificity for identifying the most important genes with large fold changes.
The test results can be visualized in an MD plot:
> plotMD(tr, status=is.de, values=c(1,-1), col=c("red","blue"),
+ legend="topright")
The method evaluates variability as well as the magnitude of change of expression values and therefore is not equivalent to a simple fold change cutoff. Nevertheless, all the statistically significant expression changes have logFC greater than 0.8 and almost all (97%) are greater than 0.9. These values compare to the threshold value of \(\log_2(1.5) = 0.58\). In general, an estimated logFC must exceed the TREAT threshold by a number of standard errors for it to be called significant. In other words, the whole confidence interval for the logFC must clear the threshold rather than just the estimated value itself. It is better to interpret the threshold as the FC below which we are definitely not interested in the gene rather than the FC above which we are interested in the gene.
The value of the FC threshold can be varied depending on the dataset.
In the presence of a huge number of DE genes, a relatively large FC threshold may be appropriate to narrow down the search to genes of interest.
In the absence of DE genes, on the other hand, a small or even no FC threshold shall be used.
If the threshold level is set to zero, then glmTreat
becomes equivalent to glmQLFTest
in the workflow shown here.
In general, using glmTreat
to reduce the number of DE genes is better than simply reducing the FDR cutoff, because glmTreat
prioritizes genes with larger changes that are likely to be more biologically significant.
glmTreat
can also be used with edgeR pipelines other than quasi-likelihood, although we don’t demonstrate that here.
Heatmaps are a popular way to display differential expression results for publication purposes.
To create a heatmap, we first convert the read counts into log2-counts-per-million (logCPM) values.
This can be done with the cpm
function:
> logCPM <- cpm(y, prior.count=2, log=TRUE)
> rownames(logCPM) <- y$genes$Symbol
> colnames(logCPM) <- paste(y$samples$group, 1:2, sep="-")
The introduction of prior.count
is to avoid undefined values and to reduce the variability of the logCPM values for genes with low counts.
Larger values for prior.count
shrink the logFCs for low count genes towards zero.
We will create a heatmap to visualize the top 30 DE genes according to the TREAT test between B.lactating
and B.pregnant
.
The advantage of a heatmap is that it can display the expression pattern of the genes across all the samples.
Visualization of the results is aided by clustering together genes that have correlated expression patterns.
First we select the logCPM values for the 30 top genes:
> o <- order(tr$table$PValue)
> logCPM <- logCPM[o[1:30],]
A heat map can then be produced by the coolmap
function:
> coolmap(logCPM, margins=c(7,7), lhei=c(1,6), lwid=c(1,3))
By default, coolmap
clusters genes by correlation (highly correlated genes are closest) and clusters samples based on Euclidean distance between the expression values.
The coolmap has placed the basal samples on the right and the luminal samples on the left.
In each case, the virgin and pregnant samples are more like each other than the lactacting samples.
As expected, the two replicate samples from each group are clustered together.
There a number of other R functions that can create heatmaps, but coolmap
is the simplest because the default clustering metrics are chosen to be appropriate for expression data.
The differential expression analysis comparing two groups can be easily extended to comparisons between three or more groups. This is done by creating a matrix of independent contrasts. In this manner, users can perform a one-way analysis of deviance (ANODEV) for each gene (McCullagh and Nelder 1989).
Suppose we want to compare the three groups in the luminal population, i.e., virgin, pregnant and lactating. An appropriate contrast matrix can be created as shown below, to make pairwise comparisons between all three groups:
> con <- makeContrasts(
+ L.PvsL = L.pregnant - L.lactating,
+ L.VvsL = L.virgin - L.lactating,
+ L.VvsP = L.virgin - L.pregnant, levels=design)
The QL F-test is then applied to identify genes that are DE between the three groups.
This combines the three pairwise comparisons into a single F-statistic and p-value.
The top set of significant genes can be displayed with topTags
:
> res <- glmQLFTest(fit, contrast=con)
> topTags(res)
Coefficient: LR test on 2 degrees of freedom
Length Symbol logFC.L.PvsL logFC.L.VvsL logFC.L.VvsP logCPM F
19242 2021 Ptn -1.54 7.26 8.801 7.97 2382
13645 4757 Egf -5.36 -7.22 -1.864 3.68 1119
52150 4089 Kcnk6 -2.42 -7.00 -4.579 5.91 1019
12992 765 Csn1s2b -8.55 -11.36 -2.811 10.19 1053
15439 1345 Hp 1.08 5.42 4.336 4.93 988
14183 5346 Fgfr2 -1.15 3.95 5.096 7.39 954
20856 1793 Stc2 -1.81 3.20 5.006 6.11 917
11941 7050 Atp2b2 -7.37 -10.56 -3.190 6.61 1136
13358 1678 Slc25a1 -4.13 -4.91 -0.784 7.50 890
17068 691 Ly6d 3.42 9.24 5.819 4.69 886
PValue FDR
19242 3.16e-17 4.97e-13
13645 3.95e-15 2.75e-11
52150 7.17e-15 2.75e-11
12992 8.55e-15 2.75e-11
15439 8.76e-15 2.75e-11
14183 1.10e-14 2.75e-11
20856 1.41e-14 2.75e-11
11941 1.59e-14 2.75e-11
13358 1.70e-14 2.75e-11
17068 1.75e-14 2.75e-11
Note that the three contrasts of pairwise comparisons are linearly dependent.
Constructing the contrast matrix with any two of the contrasts would be sufficient for an ANODEV test.
If the contrast matrix contains all three possible pairwise comparisons, then only the log-fold changes of the first two contrasts are shown in the output of topTags
.
The flexibility of the GLM framework makes it possible to specify arbitrary contrasts for differential expression tests. Suppose we are interested in testing whether the change in expression between lactating and pregnant mice is the same for basal cells as it is for luminal cells. In statistical terminology, this is the interaction effect between mouse status and cell type. The contrast corresponding to this testing hypothesis can be made as follows.
> con <- makeContrasts(
+ (L.lactating-L.pregnant)-(B.lactating-B.pregnant),
+ levels=design)
Then the QL F-test is conducted to identify genes that are DE under this contrast.
The top set of DE genes are viewed with topTags
.
> res <- glmQLFTest(fit, contrast=con)
> topTags(res)
Coefficient: -1*B.lactating 1*B.pregnant 1*L.lactating -1*L.pregnant
Length Symbol logFC logCPM F PValue FDR
19041 6277 Ppl -4.62 6.97 526 8.43e-12 1.33e-07
231991 2873 Creb5 -5.61 4.87 440 2.58e-11 2.00e-07
20512 4206 Slc1a3 5.03 3.65 413 3.82e-11 2.00e-07
217294 1952 BC006965 -3.88 4.68 371 7.46e-11 2.58e-07
14598 2022 Ggt1 3.18 6.38 358 9.30e-11 2.58e-07
13358 1678 Slc25a1 3.47 7.50 355 9.84e-11 2.58e-07
192166 4558 Sardh 2.92 5.11 340 1.28e-10 2.88e-07
19659 2628 Rbp1 -4.39 6.83 337 1.51e-10 2.97e-07
67547 3707 Slc39a8 6.19 5.07 376 1.72e-10 3.01e-07
14063 2768 F2rl1 -3.92 5.62 303 2.61e-10 3.92e-07
We now consider the problem of interpreting the differential expression results in terms of higher order biological processes or molecular pathways. One of the most common used resources is gene ontology (GO) databases, which annotate genes according to a dictionary of annotation terms. A simple and often effective way to interpret the list of DE genes is to count the number of DE genes that are annotated with each possible GO term. GO terms that occur frequently in the list of DE genes are said to be over-represented or enriched.
In edgeR, GO analyses can be conveniently conducted using the goana
function.
Here were apply goana
to the output of the TREAT analysis comparing B.lactating
to B.pregant
.
The top most significantly enriched GO terms can be viewed with topGO
.
> go <- goana(tr, species="Mm")
> topGO(go, n=15)
Term Ont N Up Down P.Up
GO:1903047 mitotic cell cycle process BP 608 8 84 0.975
GO:0007059 chromosome segregation BP 277 1 54 0.999
GO:0000070 mitotic sister chromatid segregation BP 138 0 38 1.000
GO:0000819 sister chromatid segregation BP 166 0 41 1.000
GO:0022402 cell cycle process BP 983 16 108 0.955
GO:0051301 cell division BP 524 4 74 0.998
GO:0000278 mitotic cell cycle BP 746 9 91 0.992
GO:0000280 nuclear division BP 342 6 58 0.815
GO:0098813 nuclear chromosome segregation BP 219 1 45 0.995
GO:0140014 mitotic nuclear division BP 239 2 47 0.977
GO:0000776 kinetochore CC 126 1 34 0.950
GO:0000775 chromosome, centromeric region CC 179 1 40 0.986
GO:0007049 cell cycle BP 1428 20 132 0.997
GO:0048285 organelle fission BP 387 9 58 0.554
GO:0042254 ribosome biogenesis BP 266 0 47 1.000
P.Down
GO:1903047 1.26e-21
GO:0007059 5.21e-21
GO:0000070 1.39e-20
GO:0000819 3.50e-20
GO:0022402 1.01e-19
GO:0051301 1.12e-19
GO:0000278 1.25e-19
GO:0000280 2.08e-19
GO:0098813 1.26e-18
GO:0140014 1.38e-18
GO:0000776 3.02e-18
GO:0000775 4.78e-18
GO:0007049 1.52e-17
GO:0048285 8.20e-17
GO:0042254 1.19e-16
The goana
function automatically extracts DE genes from the tr
object, and conducts overlap tests for the up- and down-regulated DE genes separately.
By default, an FDR cutoff of 5% is used when extracting DE genes, but this can be varied.
The row names of the output are the universal identifiers of the GO terms and the Term
column gives the human-readable names of the terms.
The Ont
column shows the ontology domain that each GO term belongs to.
The three domains are: biological process (BP), cellular component (CC) and molecular function (MF).
The N
column represents the total number of genes annotated with each GO term.
The Up
and Down
columns indicate the number of genes within the GO term that are significantly up- and down-regulated in this differential expression comparison, respectively.
The P.Up
and P.Down
columns contain the p-values for over-representation of the GO term in the up- and down-regulated genes, respectively.
Note that the p-values are not adjusted for multiple testing—we would usually ignore GO terms with p-values greater than about \(10^{-5}\).
By default the output table from topGO
is sorted by the minimum of P.Up
and P.Down
.
Other options are available.
For example, topGO(go, sort="up")
lists the top GO terms that are over-represented in the up-regulated genes.
The domain of the enriched GO terms can also be specified by users.
For example, topGO(go, ontology="BP")
restricts to the top GO terms belonging to the biological process domain
while topGO(go, ontology="MF")
restricts to molecular function terms.
The goana
function uses the NCBI RefSeq annotation and requires the use of Entrez Gene Identifiers.
Another popular annotation database is the Kyoto Encyclopedia of Genes and Genomes (KEGG).
Much smaller than GO, this is a curated database of molecular pathways and disease signatures.
A KEGG analysis can be done exactly as for GO, but using the kegga
function:
> keg <- kegga(tr, species="Mm")
> topKEGG(keg, n=15, truncate=34)
Pathway N Up Down P.Up
path:mmu03008 Ribosome biogenesis in eukaryot... 76 0 19 1.00e+00
path:mmu04110 Cell cycle 119 0 20 1.00e+00
path:mmu05150 Staphylococcus aureus infection 36 1 11 5.74e-01
path:mmu04972 Pancreatic secretion 68 9 4 2.77e-05
path:mmu00100 Steroid biosynthesis 18 5 0 4.54e-05
path:mmu00900 Terpenoid backbone biosynthesis 21 5 0 1.02e-04
path:mmu04970 Salivary secretion 63 8 7 1.04e-04
path:mmu04610 Complement and coagulation casc... 50 3 9 1.12e-01
path:mmu00240 Pyrimidine metabolism 52 0 9 1.00e+00
path:mmu04925 Aldosterone synthesis and secre... 76 8 6 3.91e-04
path:mmu04911 Insulin secretion 62 7 5 5.88e-04
path:mmu05144 Malaria 39 2 7 2.31e-01
path:mmu00983 Drug metabolism - other enzymes 51 2 8 3.36e-01
path:mmu04640 Hematopoietic cell lineage 63 2 9 4.35e-01
path:mmu04510 Focal adhesion 187 12 8 1.53e-03
P.Down
path:mmu03008 3.69e-10
path:mmu04110 1.80e-07
path:mmu05150 2.08e-07
path:mmu04972 3.41e-01
path:mmu00100 1.00e+00
path:mmu00900 1.00e+00
path:mmu04970 1.88e-02
path:mmu04610 2.60e-04
path:mmu00240 3.53e-04
path:mmu04925 1.11e-01
path:mmu04911 1.30e-01
path:mmu05144 1.28e-03
path:mmu00983 1.46e-03
path:mmu04640 1.49e-03
path:mmu04510 5.66e-01
The output from topKEGG
is the same as from topGO
except that row names become KEGG pathway IDs, Term
becomes Pathway
and there is no Ont
column.
Both the GO and KEGG analyses show that the cell cycle pathway is strongly down-regulated upon lactation in mammary stem cells.
By default, the kegga
function automatically reads the latest KEGG annotation from the Internet each time it is run.
The KEGG database uses Entrez Gene Ids, and the kegga
function assumes these are available as the row names of tr
.
The GO and KEGG analyses shown above are relatively simple analyses that rely on a list of DE genes. The list of DE genes is overlapped with the various GO and KEGG annotation terms. The results will depend on the significance threshold that is used to assess differential expression.
If the aim is to test for particular gene expression signatures or particular pathways, a more nuanced approach is to conduct a roast
or fry
gene set test (Wu et al. 2010).
These functions test whether a set of genes is DE, assessing the whole set of genes as a whole.
Gene set tests consider all the genes in the specified set and do not depend on any pre-emptive significance cutoff.
The set of genes can be chosen to be representative of any pathway or phenotype of interest.
roast
gives p-values using random rotations of the residual space.
In the edgeR context, fry
is generally recommended over roast
.
fry
gives an accurate analytic approximation to the results that roast
would give, with default settings, if an extremely large number of rotations was used.
Here, suppose we are interested in two GO terms related to cytokinesis. Each GO term is used to define a set of genes annotated with that term. The names of these terms are shown below:
> library(GO.db)
> cyt.go <- c("GO:0032465", "GO:0000281")
> term <- select(GO.db, keys=cyt.go, columns="TERM")
> term
GOID TERM
1 GO:0032465 regulation of cytokinesis
2 GO:0000281 mitotic cytokinesis
The first step is to extract the genes associated with each GO term from the GO database. This produces a list of two components, one for each GO term. Each component is a vector of Entrez Gene IDs for that GO term:
> Rkeys(org.Mm.egGO2ALLEGS) <- cyt.go
> cyt.go.genes <- as.list(org.Mm.egGO2ALLEGS)
Suppose the comparison of interest is between the virgin and lactating groups in the basal population.
We can use fry
to test whether the cytokinesis GO terms are DE for this comparison:
> B.VvsL <- makeContrasts(B.virgin-B.lactating, levels=design)
> fry(y, index=cyt.go.genes, design=design, contrast=B.VvsL)
NGenes Direction PValue FDR PValue.Mixed FDR.Mixed
GO:0032465 70 Up 0.00106 0.00212 6.19e-06 1.24e-05
GO:0000281 68 Up 0.00840 0.00840 1.92e-05 1.92e-05
Each row of the output corresponds to a gene set.
The NGenes
column provides the number of genes in each set.
The Direction
column indicates the net direction of change.
The PValue
column gives the two-sided p-value for testing whether the set is DE as a whole, either up or down.
The PValue.Mixed
column gives a p-value for testing whether genes in the set tend to be DE, without regard to direction.
The PValue
column is appropriate when genes in the set are expected to be co-regulated, all or most changing expression in the same direction.
The PValue.Mixed
column is appropriate when genes in the set are not necessarily co-regulated or may be regulated in different directions for the contrast in question.
FDRs are calculated from the corresponding p-values across all sets.
The results of a gene set test can be viewed in a barcode plot produced by the barcodeplot
function.
Suppose visualization is performed for the gene set defined by the GO term GO:0032465:
> res <- glmQLFTest(fit, contrast=B.VvsL)
> index <- rownames(fit) %in% cyt.go.genes[[1]]
> barcodeplot(res$table$logFC, index=index, labels=c("B.lactating","B.virgin"),
+ main=cyt.go[1])
In the plot, all genes are ranked from left to right by increasing log-fold change for the contrast and the genes within the gene set are represented by vertical bars, forming the barcode-like pattern.
The curve (or worm) above the barcode shows the relative local enrichment of the bars in each part of the plot.
The dotted horizontal line indicates neutral enrichment; the worm above the dotted line shows enrichment while the worm below the dotted line shows depletion.
In this particular barcode plot the worm shows enrichment on the right for positive logFCs, and depletion on the left for negative logFCs.
The conclusion is that genes associated with this GO term tend to be up-regulated in the basal cells of virgin mice compared to lactating mice, confirming the result of the fry
test above.
Finally we demonstrate a gene set enrichment style analysis using the Molecular Signatures Database (MSigDB) (Subramanian et al. 2005). We will use the C2 collection of the MSigDB, which is a collection of nearly 5000 curated gene sets, each representing the molecular signature of a particular biological process or phenotype. The MSigDB itself is purely human, but the Walter and Eliza Hall Institute (WEHI) maintains a mouse version of the database. We load the mouse version of the C2 collection from the WEHI website:
> load(url("http://bioinf.wehi.edu.au/software/MSigDB/mouse_c2_v5p1.rdata"))
This will load Mm.c2
, which is a list of gene sets, each a vector of Entrez Ids.
This can be converted to a list of index numbers:
> idx <- ids2indices(Mm.c2,id=rownames(y))
First we compare virgin stem cells to virgin luminal cells:
> BvsL.v <- makeContrasts(B.virgin - L.virgin, levels=design)
> cam <- camera(y, idx, design, contrast=BvsL.v, inter.gene.cor=0.01)
> options(digits=2)
> head(cam,14)
NGenes Direction PValue
LIM_MAMMARY_STEM_CELL_UP 784 Up 1.9e-43
LIM_MAMMARY_LUMINAL_MATURE_DN 169 Up 3.0e-25
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION 80 Up 3.4e-20
LIM_MAMMARY_STEM_CELL_DN 666 Down 1.9e-19
FARMER_BREAST_CANCER_CLUSTER_4 75 Up 3.7e-19
NABA_BASEMENT_MEMBRANES 52 Up 1.4e-17
HAEGERSTRAND_RESPONSE_TO_IMATINIB 35 Up 3.4e-17
ROZANOV_MMP14_TARGETS_SUBSET 83 Up 4.5e-16
REACTOME_COLLAGEN_FORMATION 70 Up 1.2e-15
REACTOME_NCAM1_INTERACTIONS 71 Up 2.0e-15
OXFORD_RALB_TARGETS_UP 27 Up 3.9e-15
ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE 149 Up 6.9e-15
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN 68 Up 1.1e-14
LIM_MAMMARY_LUMINAL_PROGENITOR_UP 92 Down 1.6e-14
FDR
LIM_MAMMARY_STEM_CELL_UP 9.1e-40
LIM_MAMMARY_LUMINAL_MATURE_DN 7.1e-22
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION 5.3e-17
LIM_MAMMARY_STEM_CELL_DN 2.2e-16
FARMER_BREAST_CANCER_CLUSTER_4 3.5e-16
NABA_BASEMENT_MEMBRANES 1.1e-14
HAEGERSTRAND_RESPONSE_TO_IMATINIB 2.3e-14
ROZANOV_MMP14_TARGETS_SUBSET 2.7e-13
REACTOME_COLLAGEN_FORMATION 6.1e-13
REACTOME_NCAM1_INTERACTIONS 9.3e-13
OXFORD_RALB_TARGETS_UP 1.7e-12
ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE 2.7e-12
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN 4.1e-12
LIM_MAMMARY_LUMINAL_PROGENITOR_UP 5.4e-12
With a large gene set collection, setting inter.gene.cor = 0.01
gives a good compromise between biological interpretability and FDR control.
As expected, the mammary stem cell and mammary luminal cell signatures from Lim et al (Lim et al. 2010) are top-ranked, and in the expected directions.
We can visualize the top signature, combining the up and down mammary stem cell signatures to make a bi-directional signature set:
> res <- glmQLFTest(fit, contrast=BvsL.v)
> barcodeplot(res$table$logFC,
+ index=idx[["LIM_MAMMARY_STEM_CELL_UP"]],
+ index2=idx[["LIM_MAMMARY_STEM_CELL_DN"]],
+ labels=c("L.virgin","B.virgin"),
+ main="LIM_MAMMARY_STEM_CELL",
+ alpha=1)
This workflow depends on various packages from version 3.3 of the Bioconductor project, running on R version 3.3.0 or higher. The complete list of the packages used for this workflow are shown below:
> sessionInfo()
R version 3.6.0 (2019-04-26)
Platform: x86_64-pc-linux-gnu (64-bit)
Running under: Ubuntu 18.04.2 LTS
Matrix products: default
BLAS: /home/biocbuild/bbs-3.9-bioc/R/lib/libRblas.so
LAPACK: /home/biocbuild/bbs-3.9-bioc/R/lib/libRlapack.so
locale:
[1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
[3] LC_TIME=en_US.UTF-8 LC_COLLATE=C
[5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
[7] LC_PAPER=en_US.UTF-8 LC_NAME=C
[9] LC_ADDRESS=C LC_TELEPHONE=C
[11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
attached base packages:
[1] parallel stats4 stats graphics grDevices utils datasets
[8] methods base
other attached packages:
[1] RnaSeqGeneEdgeRQL_1.8.0 GO.db_3.8.2 org.Mm.eg.db_3.8.2
[4] AnnotationDbi_1.46.0 IRanges_2.18.0 S4Vectors_0.22.0
[7] Biobase_2.44.0 BiocGenerics_0.30.0 gplots_3.0.1.1
[10] edgeR_3.26.0 limma_3.40.0 BiocStyle_2.12.0
loaded via a namespace (and not attached):
[1] Rcpp_1.0.1 highr_0.8 compiler_3.6.0
[4] BiocManager_1.30.4 bitops_1.0-6 tools_3.6.0
[7] statmod_1.4.30 digest_0.6.18 bit_1.1-14
[10] evaluate_0.13 RSQLite_2.1.1 memoise_1.1.0
[13] lattice_0.20-38 pkgconfig_2.0.2 DBI_1.0.0
[16] yaml_2.2.0 xfun_0.6 stringr_1.4.0
[19] knitr_1.22 gtools_3.8.1 caTools_1.17.1.2
[22] locfit_1.5-9.1 bit64_0.9-7 grid_3.6.0
[25] rmarkdown_1.12 bookdown_0.9 gdata_2.18.0
[28] blob_1.1.1 magrittr_1.5 splines_3.6.0
[31] htmltools_0.3.6 KernSmooth_2.23-15 stringi_1.4.3
We now revisit the question of recreating the matrix of read counts from the raw sequence reads.
Unlike the above workflow, which works for any version of R, read alignment requires Unix or Mac OS and, in practice, a high performance Unix server is recommended.
Read alignment and read counting require only one Bioconductor package, Rsubread.
However the fastq-dump
utility from the SRA Toolkit is also required to convert from SRA to FASTQ format.
This can be downloaded from the NCBI website (http://www.ncbi.nlm.nih.gov/Traces/sra/?view=software) and installed on any Unix system.
The first task is to download the raw sequence files, which are stored in SRA format on the SRA repository.
The SRA files need to be unpacked into FASTQ format using the fastq-dump
utility.
The following R code makes a system call to fastq-dump
to download each SRA file and convert it to FASTQ format:
for (sra in targets$SRA) system(paste("fastq-dump", sra))
The fastq-dump
utility automatically downloads the specified SRA data set from the internet.
The above code will produce 12 FASTQ files, in the current working directory, with file names given by the following vector:
all.fastq <- paste0(targets$SRA, ".fastq")
Sequencers typically store base-calling quality scores for each read in the FASTQ files.
Rsubread’s qualityScores
function can be used to extract these scores from any particular file:
QS <- qualityScores("SRR1552444.fastq")
The boxplot function provides a compact way to view the quality scores by position across all reads:
boxplot(QS, ylab="Quality score", xlab="Base position",
main="SRR1552444.fastq", cex=0.25, col="orange")
The vertical axis shows the Phred quality score, equal to \(-10\log_{10}(p)\) where \(p\) is the probability of an erroneous call. The maximum possible value is 40, and all values above 10 correspond to extremely small error probabilities. The horizontal axis shows position within a read. The file contains 100bp single-end reads, so the scale is from 1 to 100. The plot displays a compact boxplot at each base position. As is very commonly observed, the quality scores are best in the middle of the reads and decrease slightly towards the start and end of the reads. However the quality remains generally good even near the ends of the reads: the scores would need to be very much lower than this before they would cause problems for the alignment. Similar plots can be made for each of the FASTQ files.
Before the sequence reads can be aligned, we need to build an index for the GRCm38/mm10 (Dec 2011) build of the mouse genome. Most laboratories that use Rsubread regularly will already have an index file prepared, as this is a once-off operation for each genome release. If you are using Rsubread for mouse for the first time, then the latest mouse genome build can be downloaded from the NCBI webpage (https://www.ncbi.nlm.nih.gov/assembly/GCF_000001635.26). The full URL is:
ftp://ftp.ncbi.nlm.nih.gov/genomes/all/GCF/000/001/635/GCF_000001635.26_GRCm38.p6/GCF_000001635.26_GRCm38.p6_genomic.fna.gz
(Note that this link is for patch 6 of the RefSeq mm10 build, which is valid at the time of writing in May 2018. The link will change as new patches are released periodically.) An index can then be built by:
library(Rsubread)
buildindex(basename = "mm10",
reference = "GCF_000001635.26_GRCm38.p6_genomic.fna.gz")
The sequence reads can now be aligned to the mouse genome using the align
function:
all.bam <- sub(".fastq", ".bam", all.fastq)
align(index="mm10", readfile1=all.fastq, input_format="FASTQ",
output_file=all.bam)
This produces a set of BAM files containing the read alignments for each RNA library.
The mapping proportions can be summarized by the propmapped
function:
> propmapped(all.bam)
Samples NumTotal NumMapped PropMapped
1 SRR1552450.bam 30109290 26577308 0.883
2 SRR1552451.bam 28322351 24794251 0.875
3 SRR1552452.bam 31688348 27937620 0.882
4 SRR1552453.bam 29614284 26074034 0.880
5 SRR1552454.bam 27225012 24381742 0.896
6 SRR1552455.bam 25433157 22813815 0.897
7 SRR1552444.bam 27919481 23927833 0.857
8 SRR1552445.bam 29731031 25487822 0.857
9 SRR1552446.bam 29879070 25500318 0.853
10 SRR1552447.bam 29245388 25187577 0.861
11 SRR1552448.bam 31425424 27326500 0.870
12 SRR1552449.bam 31276061 27204156 0.870
Ideally, the proportion of mapped reads should be above 80%. By default, only reads with unique mapping locations are reported by Rsubread as being successfully mapped. Restricting to uniquely mapped reads is recommended, as it avoids spurious signal from non-uniquely mapped reads derived from, e.g., repeat regions.
The read counts for each gene can be quantified using the featureCounts
function in Rsubread.
Conveniently, the Rsubread package includes inbuilt NCBI RefSeq annotation of the mouse and human genomes.
featureCounts
generates a matrix of read counts for each gene in each sample:
fc <- featureCounts(all.bam, annot.inbuilt="mm10")
The output is a simple list, containing the matrix of counts (counts
), a data frame of gene characteristics (annotation
), a vector of file names (targets
) and summary mapping statistics (stat
):
> names(fc)
[1] "counts" "annotation" "targets" "stat"
The row names of fc$counts
are the Entrez gene identifiers for each gene.
The column names are the output file names from align
, which we simplify here for brevity:
> colnames(fc$counts) <- rownames(targets)
The first six rows of the counts matrix are shown below.
> head(fc$counts)
MCL1.DG MCL1.DH MCL1.DI MCL1.DJ MCL1.DK MCL1.DL MCL1.LA
497097 438 299 65 237 354 287 0
100503874 1 0 1 1 0 4 0
100038431 0 0 0 0 0 0 0
19888 1 1 0 0 0 0 10
20671 106 181 82 104 43 83 16
27395 309 232 339 290 291 270 558
MCL1.LB MCL1.LC MCL1.LD MCL1.LE MCL1.LF
497097 0 0 0 0 0
100503874 0 0 0 0 0
100038431 0 0 0 0 0
19888 3 10 2 0 0
20671 25 18 8 3 10
27395 468 488 332 312 344
Finally, a DGEList
object can be assembled by:
y <- DGEList(fc$counts, group=group)
y$genes <- fc$annotation[, "Length", drop=FALSE]
This html document was generated as a vignette of the RnaSeqGeneEdgeRQL package, which can be installed by running
install.packages("BiocManager")
BiocManager::install("RnaSeqGeneEdgeRQL")
at the R prompt.
Except for the targets file targets.txt
, all data analyzed in the workflow is read automatically from public websites as part of the code.
All software used is publicly available as part of Bioconductor (Release 3.3 or later), except for the fastq-dump
utility, which can be downloaded from NCBI website as described in the text.
The article includes the complete code necessary to reproduce the analyses shown.
The original Bioconductor 3.3 version of this workflow, including a pdf article version and a corresponding Rnw file, is available from http://f1000research.com/articles/5-1438 and http://bioinf.wehi.edu.au/edgeR/F1000Research2016 (Chen, Lun, and Smyth 2016).
This work was supported by the National Health and Medical Research Council (Fellowship 1058892 and Program 1054618 to G.K.S, Independent Research Institutes Infrastructure Support to the Walter and Eliza Hall Institute) and by a Victorian State Government Operational Infrastructure Support Grant.
The authors thank Wei Shi and Yang Liao for advice with Rsubread and Yifang Hu for creating the mouse version of the MSigDB. We also wish to acknowledge the early developers of the quasi-likelihood testing approach. Davis McCarthy authored the first versions of the quasi-likelihood functions in edgeR in February 2011 and Steve Lund and Dan Nettleton worked independently on QuasiSeq around the same time. We thank Steve Lund and Dan Nettleton for a valuable and enjoyable collaboration that lead to Lund et al (Lund et al. 2012).
Please cite this workflow article as
Chen, Yunshun, A. T. L. Lun, and G. K. Smyth. 2016. “From Reads to Genes to Pathways: Differential Expression Analysis of RNA-Seq Experiments Using Rsubread and the edgeR Quasi-Likelihood Pipeline.” F1000Research 5:1438.
Burden, C. J., S. E. Qureshi, and S. R. Wilson. 2014. “Error Estimates for the Analysis of Differential Expression from RNA-seq Count Data.” PeerJ 2:e576.
Chen, Yunshun, A. T. L. Lun, and G. K. Smyth. 2016. “From Reads to Genes to Pathways: Differential Expression Analysis of RNA-Seq Experiments Using Rsubread and the edgeR Quasi-Likelihood Pipeline.” F1000Research 5:1438. https://doi.org/10.12688/f1000research.8987.2.
Fu, N. Y., A. Rios, B. Pal, R. Soetanto, A. T. L. Lun, K. Liu, T. Beck, et al. 2015. “EGF-Mediated Induction of Mcl-1 at the Switch to Lactation Is Essential for Alveolar Cell Survival.” Nature Cell Biology 17 (4):365–75.
Huber, W., V. J. Carey, R. Gentleman, S. Anders, M. Carlson, B. S. Carvalho, H. C. Bravo, et al. 2015. “Orchestrating High-Throughput Genomic Analysis with Bioconductor.” Nature Methods 12 (2):115–21.
Law, C. W., Y. Chen, W. Shi, and G. K. Smyth. 2014. “Voom: Precision Weights Unlock Linear Model Analysis Tools for RNA-Seq Read Counts.” Genome Biology 15:R29.
Liao, Y., G. K. Smyth, and W. Shi. 2013. “The Subread Aligner: Fast, Accurate and Scalable Read Mapping by Seed-and-Vote.” Nucleic Acids Research 41 (10):e108.
———. 2014. “featureCounts: An Efficient General-Purpose Read Summarization Program.” Bioinformatics 30 (7):923–30. https://doi.org/10.1093/bioinformatics/btt656.
Lim, E., D. Wu, B. Pal, T. Bouras, M.L. Asselin-Labat, F. Vaillant, H. Yagita, G.J. Lindeman, G.K. Smyth, and J.E. Visvader. 2010. “Transcriptome Analyses of Mouse and Human Mammary Cell Subpopulations Reveal Multiple Conserved Genes and Pathways.” Breast Cancer Research 12:R21.
Love, M. I., W. Huber, and S. Anders. 2014. “Moderated Estimation of Fold Change and Dispersion for RNA-seq Data with DESeq2.” Genome Biology 15 (12):550.
Lun, A. T. L., K. Bach, and J. C. Marioni. 2016. “Pooling Across Cells to Normalize Single-Cell RNA Sequencing Data with Many Zero Counts.” Genome Biology 17:75.
Lun, A. T. L., Y. Chen, and G. K. Smyth. 2016. “It’s DE-Licious: A Recipe for Differential Expression Analyses of RNA-Seq Experiments Using Quasi-Likelihood Methods in edgeR.” Methods in Molecular Biology 1418:391–416.
Lun, A. T. L., and G. K. Smyth. 2014. “De Novo Detection of Differentially Bound Regions for ChIP-seq Data Using Peaks and Windows: Controlling Error Rates Correctly.” Nucleic Acids Research 42 (11):e95.
———. 2015. “diffHic: A Bioconductor Package to Detect Differential Genomic Interactions in Hi-C Data.” BMC Bioinformatics 16:258.
Lund, S. P., D. Nettleton, D. J. McCarthy, and G. K. Smyth. 2012. “Detecting Differential Expression in RNA-Sequence Data Using Quasi-Likelihood with Shrunken Dispersion Estimates.” Statistical Applications in Genetics and Molecular Biology 11 (5):Article 8.
McCarthy, D. J., Y. Chen, and G. K. Smyth. 2012. “Differential Expression Analysis of Multifactor RNA-Seq Experiments with Respect to Biological Variation.” Nucleic Acids Research 40 (10):4288–97. https://doi.org/10.1093/nar/gks042.
McCarthy, D. J., and G. K. Smyth. 2009. “Testing Significance Relative to a Fold-Change Threshold Is a TREAT.” Bioinformatics 25 (6):765–71. https://doi.org/10.1093/bioinformatics/btp053.
McCullagh, P., and John A. Nelder. 1989. Generalized Linear Models. 2nd ed. Boca Raton, Florida: Chapman & Hall/CRC.
Phipson, B., S. Lee, I. J. Majewski, W. S. Alexander, and G. K. Smyth. 2016. “Robust Hyperparameter Estimation Protects Against Hypervariable Genes and Improves Power to Detect Differential Expression.” Annals of Applied Statistics 10 (2):946–63. https://doi.org/10.1214/16-AOAS920.
Risso, D., J. Ngai, T. P. Speed, and Dudoit S. 2014. “Normalization of RNA-Seq Data Using Factor Analysis of Control Genes or Samples.” Nat Biotechnol. 32 (9):896–902.
Ritchie, M. E., B. Phipson, D. Wu, Y. Hu, C. W. Law, W. Shi, and G. K. Smyth. 2015. “limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies.” Nucleic Acids Research 43 (7). Oxford Univ Press:e47.
Robinson, M. D., D. J. McCarthy, and G. K. Smyth. 2010. “edgeR: A Bioconductor Package for Differential Expression Analysis of Digital Gene Expression Data.” Bioinformatics 26 (1):139–40.
Robinson, M. D., and A. Oshlack. 2010. “A Scaling Normalization Method for Differential Expression Analysis of RNA-seq Data.” Genome Biology 11 (3):R25.
Robinson, M. D., and G. K. Smyth. 2007. “Moderated Statistical Tests for Assessing Differences in Tag Abundance.” Bioinformatics 23 (21):2881–7. https://doi.org/10.1093/bioinformatics/btm453.
———. 2008. “Small-Sample Estimation of Negative Binomial Dispersion, with Applications to SAGE Data.” Biostatistics 9 (2):321–32. https://doi.org/10.1093/biostatistics/kxm030.
Smyth, G. K. 2004. “Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments.” Statistical Applications in Genetics and Molecular Biology 3 (1):Article 3. http://www.statsci.org/smyth/pubs/ebayes.pdf.
Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, et al. 2005. “Gene Set Enrichment Analysis: A Knowledge-Based Approach for Interpreting Genome-Wide Expression Profiles.” Proceedings of the National Academy of Sciences of the United States of America 102 (43):15545–50.
Wu, D., E. Lim, F. Vaillant, M. L. Asselin-Labat, J. E. Visvader, and G. K. Smyth. 2010. “ROAST: Rotation Gene Set Tests for Complex Microarray Experiments.” Bioinformatics 26 (17):2176–82. https://doi.org/10.1093/bioinformatics/btq401.
Wu, Di, Yifang Hu, Stephen Tong, Bryan RG Williams, Gordon K Smyth, and Michael P Gantier. 2013. “The Use of miRNA Microarrays for the Analysis of Cancer Samples with Global miRNA Decrease.” RNA 19 (7):876–88.